Leveraging mRNA Platform Technologies to Enable Pandemic Supply of COVID-19 Vx.
Khurram Sunasara, PhD
Group leader in Pfizer Inc.’s Bioprocess R&D group, Saint Louis, MO, USA
Co-lead of Pharmaceutical Science’s COVID-19 mRNA vaccine drug substance team responsible for process development, scale-up and process characterization
Applying the AdVacPlatform to Development of a COVID-19 Vaccine
Joanke Graveland-Bikker PhD
Senior Technical Integrator at Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Pepijn Burgers PhD
Associate Scientific Director at Janssen Vaccines and Prevention B.V., Leiden, Netherlands